Skip to main content
. 2014 Dec 23;49(4):216–227. doi: 10.5045/br.2014.49.4.216

Table 2.

Frequency and prognostic significance of somatic molecular mutations in myelodysplastic syndrome.

graphic file with name br-49-216-i002.jpg

a)An adverse prognostic impact [30]. b)Indicates the frequency in refractory anemia with ring sideroblasts. c)The prognostic impact of mutations in these genes cannot be statistically assessed due to the low frequency of mutations. d)A poor overall survival was associated mainly with STAG2 mutations in MDS patients [102].